PMID: 42112329

Atorvastatin as a pleiotropic anticancer agent: mechanisms, evidence, and therapeutic repurposing potential.

Su Jiaqi, Ji Caifeng, Niu Xinlu, Wu Ziming, Shi Lingxue, Kang Longfei, Li Dongyun, Ma Yinling, Pang Guoxun, Ma Xue

Frontiers in immunology · 2026

Vol. 17, pp. 1808729

This entry links to third-party literature. For research use only.